Zurn Elkay Water Solutions Cor (NYSE:ZWS) Receives Consensus Rating of "Hold" from Brokerages
Nine analysts have issued a consensus "Hold" rating for Zurn Elkay Water Solutions Cor (NYSE:ZWS), with an average one-year price target of $51.63. Insiders have recently sold significant shares, including the CEO and CFO, totaling over $31 million in the last three months. The company reported a beat on its latest quarterly earnings with $0.36 EPS against an expected $0.34 and 9.8% year-over-year revenue growth.
Upbound Stock Gains 6% After Reporting Q4 Earnings & Revenue Beat
Upbound Group, Inc. (UPBD) saw its stock rise by 6.3% after reporting Q4 2025 earnings and revenue that exceeded analyst expectations. Despite macroeconomic challenges, the company's strategic positioning, including the acquisition of Brigit and growth in Acima, contributed to increased revenue and investor confidence. Upbound also provided optimistic guidance for Q1 2026 and the full year 2026, forecasting continued revenue and EBITDA growth.
Coca-Cola's Q4 Revenue Exceeds Expectations: 2024 Outlook
Coca-Cola announced impressive Q4 and full-year 2024 earnings, exceeding expectations due to strong revenue growth, effective pricing strategies, and increased demand. The company's success is attributed to its iconic brand strength, continuous product innovation including low-sugar options, and an extensive global distribution network. Despite challenges like health concerns and competition, Coca-Cola is strategically positioned for future growth through sustainability initiatives, digital transformation, and capitalizing on emerging markets.
ACADIA Pharma Stock: What Wall Street Missed in the Latest Drop
ACADIA Pharmaceuticals is a high-conviction, high-volatility stock in the neurology and rare-disease sector, and despite recent price drops, Wall Street remains largely bullish. The company is transitioning from a single-product focus to a broader portfolio strategy, with its future valuation largely dependent on successful pipeline execution and potential M&A. Investors should consider ACADIA as a satellite growth holding, understanding the associated biotech-style volatility and aligning their investment horizon with the Street's multi-year outlook.
IHG signs second Hotel Indigo in Cairo
IHG Hotels & Resorts has signed a management agreement with JADEER GROUP to develop the Hotel Indigo Cairo New Administrative Capital, a 140-key hotel set to open in 2033. This marks the second Hotel Indigo in Cairo and will be located within a mixed-use development, catering to both corporate and leisure travelers in Egypt's new administrative and business hub. The partnership underscores IHG's confidence in the Egyptian market and JADEER GROUP's vision for distinctive developments, leveraging Hotel Indigo's design and neighbourhood-focused approach.
Parex Resources Announces Nomination of Six Directors to GeoPark’s Board
Parex Resources Inc., holding approximately an 11.8% stake in GeoPark Limited, has nominated six independent director candidates for election to GeoPark's Board. This action follows Parex's efforts to explore value-maximizing transactions for GeoPark, including a prior acquisition proposal. The nominees are experienced executives and directors aimed at ensuring an independent evaluation of shareholder value maximization options.
Telkom: Perang Harga Sudah “So Yesterday”, Kini Fokus Kualitas Layanan
Telkom, through its CEO Dian Siswarini, announced a shift in focus from price wars to service quality as its main competitive strategy. Siswarini stated that in the maturing telecommunications industry, service differentiation and network quality are now the crucial factors for success, rather than low tariffs. The company plans to leverage its extensive fiber network as a foundation to enhance overall service quality for both fixed and mobile broadband users.
Best Solana ETFs for 2026: Compare Fees, Staking Rewards & Promos
This article reviews the best Solana ETFs for 2026, comparing their fees, staking reward features, and promotional offers. It highlights options like Franklin Solana ETF (SOEZ) for its low fees, Bitwise Solana Staking ETF (BSOL) for potential staking rewards, and other funds from 21Shares, Invesco Galaxy, Fidelity, VanEck, and Grayscale, detailing each fund's cost structure and unique selling points. The article emphasizes that investors should consider long-term expense ratios, staking features, and the duration of promotional offers when choosing an ETF.
Community West Bancshares Announces Retirement of Board Member Tom L. Dobyns
Community West Bancshares (NASDAQ: CWBC) announced the retirement of Tom L. Dobyns from its Board of Directors, effective March 31, 2026. Mr. Dobyns, who joined the board in 2024 following a merger and previously served the acquired institution since 2017, is recognized for his leadership, judgment, and deep understanding of banking. His contributions to the Audit, Risk Oversight, and Retirement Committees were highlighted by Chairman Daniel J. Doyle and CEO James J. Kim.
Cooper-Standard prices $1.1B notes offering to refinance debt By Investing.com
Cooper-Standard Holdings Inc. has announced the pricing of a $1.1 billion private offering of 9.250% Senior Secured First Lien Notes due 2031 to refinance existing debt. The company plans to use the proceeds to redeem outstanding notes due in 2027 and 2026, aiming to reduce its interest burden and achieve profitability. Although the stock is down 13% over the past week, it has gained 164% over the last year, but InvestingPro analysis suggests it is currently overvalued.
Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 crore
Swiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit to a ChrysCapital-led consortium for ₹1,446 crore. This move is part of Novartis' strategy to become an innovative medicines-focused company, although it will maintain a significant presence in India through its wholly-owned subsidiary. The divestment comes as Novartis India has seen declining sales, with its key product, Vymada, facing increased generic competition.
Travelers Cos EVP Lefebvre sells $1.74 million in shares
Mojgan M. Lefebvre, EVP and Chief Technology & Operations Officer at Travelers Companies Inc (NYSE:TRV), sold over 5,800 shares of common stock for approximately $1.74 million on February 19, 2026, while also acquiring over 12,000 shares at no cost due to performance objectives. Analysts have offered varied assessments of TRV, with Raymond James raising its price target while Jefferies lowered its target, and UBS and Mizuho maintaining their ratings with adjusted price targets.
EDR Investors Have Opportunity to Lead Endeavor Group Holdings, Inc. Securities Fraud Lawsuit
Rosen Law Firm is reminding investors who sold Endeavor Group Holdings, Inc. (NYSE: EDR) Class A common stock between January 15, 2025, and March 24, 2025, of the lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Endeavor's Information Statement and other materials for a take-private merger misled investors about the true value of shares, executive earnings, and conflicts of interest. Investors damaged during this period have until March 18, 2026, to move for lead plaintiff status.
Ronaldo Kicks In $7.5M Pro2col Investment For Herbalife’s Shift Toward ‘New’ With Personalization
Cristiano Ronaldo has invested $7.5 million in Herbalife's Pro2col business, extending his collaboration with the company. This investment is aimed at supporting Herbalife's strategic shift towards personalization and new approaches in the health and wellness market. The partnership highlights a continued focus on evolving consumer health.
Fifth Third Bancorp: Why This Regional Bank Is Back on Buy Lists
Fifth Third Bancorp (FITB) is gaining renewed interest from Wall Street analysts, with recent upgrades and increased options activity. Despite trading at a discount compared to larger banks, KITB is seen as a well-positioned regional bank with solid capital, growing dividends, and conservative credit standards. The bank's performance is closely tied to interest rate cuts and deposit stability, making it an attractive option for investors looking for exposure to the U.S. consumer and regional business activity.
Clearwater Analytics CEO Sahai Sandeep sells $5.48 million in shares By Investing.com
Clearwater Analytics CEO Sandeep Sahai sold 233,813 shares of Class A Common Stock for approximately $5.48 million on February 18, 2026, while also acquiring shares through performance stock unit vesting. The company has recently been selected by Generali Deutschland AG for portfolio management and is undergoing a proposed acquisition by an investor group, leading to several analyst downgrades.
R1 RCM Stock Pops on Guidance, AI Hype — Is the Rally for Real?
R1 RCM (RCM) stock has seen a significant pop following updated guidance and renewed AI optimism, causing Wall Street analysts to quietly lift their price targets. The company, which specializes in revenue cycle management for healthcare providers, is now being viewed as a profitable growth story tied to structural US healthcare trends like labor shortages and the push for digitization. Investors are weighing whether this rally signifies a long-term rerating driven by AI and automation efficiencies or if risks related to contract concentration and regulatory changes could derail its momentum.
Exact Sciences shareholders approve merger with Abbott Laboratories
Exact Sciences Corp. shareholders have approved the proposed merger with Abbott Laboratories, making Exact Sciences a wholly-owned subsidiary of Abbott. The merger agreement passed with significant shareholder support, although the advisory vote on executive compensation was not approved. The completion of the merger is pending regulatory approvals and other customary closing conditions.
Barclays Upgrades Etsy (ETSY) to Overweight, Raises Price Target
Barclays has upgraded Etsy (ETSY) from Equal-Weight to Overweight, simultaneously increasing its price target from $62.00 to $72.00, reflecting a 16.13% increase and a more optimistic outlook. This upgrade comes despite several recent downward revisions by other analysts. Etsy, a leading e-commerce marketplace for vintage and craft goods, boasts $12.5 billion in 2024 gross merchandise volume and connects 95 million buyers with 8 million sellers.
DXC Technology Stock Spikes on Apollo–Kyndryl Bid: Buy the Rebound or Exit?
DXC Technology's stock surged after Apollo Global Management and Kyndryl made an all-cash takeover bid, turning the company into a merger-arbitrage play. The stock is currently trading below the rumored offer price, indicating market skepticism about the deal's certainty. Investors must weigh the potential for a deal closing against the risk of its failure, which would refocus attention on DXC's underlying fundamentals and turnaround challenges.
Eminence Capital Trims Amazon.com Stake, Sheds 73,281 Shares
Eminence Capital LLC, managed by Ricky Sandler, reduced its stake in Amazon.Com, Inc. by 73,281 shares. Despite recent stock volatility and concerns about a large capital expenditure plan, analysts maintain a "Strong Buy" rating for Amazon, citing strong AWS and AI investments, and growth in advertising. TipRanks' AI Analyst, Spark, rates AMZN as "Neutral" due to financial performance and earnings outlook balanced against free cash flow conversion and valuation.
Synopsys Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Synopsys, Inc. - SNPS
Kahn Swick & Foti, LLC (KSF) has initiated an investigation into Synopsys, Inc. (SNPS) concerning potential breaches of fiduciary duties by its officers and directors. This investigation follows a lawsuit filed against Synopsys by Cangrade, Inc. in February 2025, alleging misappropriation of trade secrets, breach of contract, and professional negligence, which a court recently allowed to proceed. KSF is urging long-term Synopsys shareholders to contact them to discuss their legal rights regarding these allegations.
Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
ClaimsFiler is reminding investors who incurred losses over $100,000 in Ultragenyx Pharmaceutical Inc. (RARE) to file lead plaintiff applications by April 6, 2026, in a securities class action lawsuit. The lawsuit alleges that Ultragenyx and its executives failed to disclose material information between August 3, 2023, and December 26, 2025, concerning the failure of its Phase III Orbit and Cosmic studies for setrusumab to show a statistically significant reduction in fracture rates. Following this announcement, Ultragenyx's share price dropped by approximately 42%.
Kyndryl Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Kyndryl Holdings, Inc. - KD
ClaimsFiler is reminding Kyndryl Holdings, Inc. (NYSE: KD) investors who suffered losses exceeding $100,000 to file lead plaintiff applications by April 13, 2026, in a securities class action lawsuit. The lawsuit alleges that Kyndryl and its executives failed to disclose material information between August 7, 2024, and February 9, 2026. This failure came to light when the company announced it could not timely file its Form 10-Q report and anticipated reporting material weaknesses in internal controls, alongside the departure of its CFO and General Counsel, leading to a significant stock price drop.
Ardent Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ardent Health, Inc. - ARDT
ClaimsFiler is reminding investors with losses over $100,000 in Ardent Health, Inc. (NYSE: ARDT) that the lead plaintiff deadline for a class action lawsuit is March 9, 2026. The lawsuit alleges that Ardent Health failed to disclose material information between July 18, 2024, and November 12, 2025, leading to a significant drop in share price after the company reported decreased revenue and cut financial guidance. Investors who purchased securities during this period are encouraged to visit ClaimsFiler's website for more information on their legal options.
Rosen Law Firm Encourages Apollo Global Management, Inc. Investors to Inquire About Securities Class Action Investigation - APO
The Rosen Law Firm is investigating potential securities claims against Apollo Global Management, Inc. (NYSE: APO) after a Financial Times article alleged that top Apollo executives, including CEO Marc Rowan, consulted with Jeffrey Epstein on the firm's tax affairs. This news led to a stock drop for Apollo. The firm is preparing a class action lawsuit and is encouraging investors who purchased Apollo securities to join the prospective action to recover losses.
Ardent Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ardent Health, Inc. - ARDT
ClaimsFiler is reminding investors of Ardent Health, Inc. (NYSE: ARDT) who suffered losses exceeding $100,000 that they have until March 9, 2026, to file as lead plaintiff in a securities class action lawsuit. The lawsuit alleges that Ardent Health and its executives failed to disclose material information regarding a $43 million revenue decrease due to a new accounting system, a $57.5 million cut to 2025 EBITDA guidance, and a $54 million increase in professional liability reserves, leading to a nearly 34% drop in stock price. The class period for the lawsuit is between July 18, 2024, and November 12, 2025.
Rosen Law Firm Encourages Apollo Global Management, Inc. Investors to Inquire About Securities Class Action Investigation - APO
The Rosen Law Firm is investigating potential securities claims against Apollo Global Management, Inc. (NYSE: APO) on behalf of investors. This investigation stems from allegations that Apollo issued materially misleading business information following a Financial Times article reporting discussions between Apollo executives and Jeffrey Epstein regarding the firm's tax affairs. The firm is preparing a class action lawsuit to recover losses for affected investors who purchased Apollo securities.
Kyndryl Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Kyndryl Holdings, Inc. - KD
ClaimsFiler is reminding investors who lost over $100,000 in Kyndryl Holdings, Inc. (NYSE: KD) to file lead plaintiff applications by April 13, 2026, in a securities class action lawsuit. The lawsuit alleges that Kyndryl failed to disclose material information between August 7, 2024, and February 9, 2026, including anticipated material weaknesses in internal controls and the departure of key executives. This news reportedly caused Kyndryl's shares to drop significantly.
HIVE Digital Technologies finance chief discusses record third quarter results - ICYMI
HIVE Digital Technologies reported record third-quarter revenue of $93.1 million, driven by a major expansion year and improved energy cost efficiency, particularly in Paraguay. The company is pursuing a "dual engine" strategy, combining Bitcoin mining with AI-driven high-performance computing to balance revenue streams. HIVE aims to expand its global tier one data center capacity to 540MW by year-end, with potential for further AI contract wins and margin growth.
VivoPower secures $30M for AI data centers - ICYMI
VivoPower International PLC secured $30 million in PIPE financing from strategic investors like Blue Sky Capital, even at a share price higher than its current trading value, signaling investor confidence. The company is undergoing a significant strategic transition, exiting its electric vehicle business and digital treasury operations to focus entirely on becoming a vertically integrated investor and developer of AI data centers. VivoPower plans to acquire land, secure permits and power, design, construct, and lease data centers to hyperscalers, viewing AI infrastructure as the "oil fields of the future" with substantial global demand.
Elon Musk's Tesla Must Pay $243 Milllion In 2019 Fatal Autopilot Crash As Judge Says Evidence 'More Than Supports' Liability
A federal judge in Miami upheld a $243 million jury verdict against Tesla Inc. for a 2019 fatal crash involving its Autopilot system, stating that the evidence strongly supported the jury's decision. The crash, which killed one person and severely injured another, occurred when the Tesla's driver, relying on Autopilot, expected the car to brake but it instead accelerated into an intersection. The ruling comes as Tesla faces pressure regarding its robotaxi ambitions.
BellRing Brands Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against BellRing Brands, Inc. - BRBR
ClaimsFiler is reminding investors with significant losses in BellRing Brands, Inc. (NYSE: BRBR) to file lead plaintiff applications by March 23, 2026, in a securities class action lawsuit. The lawsuit alleges that BellRing and its executives failed to disclose material information that led to substantial stock price drops, following disappointing sales outlooks announced in May and August 2025. Investors who purchased shares between November 19, 2024, and August 4, 2025, are encouraged to seek legal counsel to discuss their options.
CoreWeave Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against CoreWeave, Inc. - CRWV
ClaimsFiler is alerting investors in CoreWeave, Inc. (CRWV) who suffered losses exceeding $100,000 to a lead plaintiff deadline of March 13, 2026, in a pending securities class action lawsuit. The lawsuit alleges that CoreWeave and its executives made false and misleading statements regarding the company's ability to meet customer demand and its reliance on a single third-party data center supplier, which are claimed to have materially understated risks and overstated revenue potential. Investors who purchased CRWV securities between March 28, 2025, and December 15, 2025, are affected.
SoFi Technologies (NASDAQ:SOFI) EVP Sells $184,076.85 in Stock
SoFi Technologies (NASDAQ:SOFI) EVP Kelli Keough sold 9,755 shares of the company's stock for $184,076.85, decreasing her position by 3.21%. This insider sale follows other recent sales by Keough and comes amidst mixed analyst ratings and a "Hold" consensus for the stock. Despite the insider selling, SoFi reported strong Q4 results, exceeding revenue and EPS estimates, and provided positive guidance for Q1 and FY 2026.
Axxcess Wealth Management LLC Has $2.93 Million Stock Position in Goldman Sachs Access Treasury 0-1 Year ETF $GBIL
Axxcess Wealth Management LLC significantly increased its stake in the Goldman Sachs Access Treasury 0-1 Year ETF (GBIL) by 48.1% in the third quarter, bringing its total holdings to $2.93 million. Several other institutional investors also adjusted their positions in GBIL. The ETF, which invests in short-term US Treasury securities, recently announced a monthly dividend.
Employers Holdings, Inc. (NYSE: EIG) Swings to Q4 Loss on Elevated Claims
Employers Holdings, Inc. (NYSE: EIG) reported a net loss of $23.4 million, or $1.06 per diluted share, for Q4 2025, a significant swing from profit, driven by a 21.3% decline in revenue and elevated claims, particularly in California. For the full year 2025, net income dropped to $10.8 million from $118.6 million in 2024. The company's stock reacted negatively, falling over 10% following the announcement, as its GAAP combined ratio deteriorated to 110.9%.
Septerna president Bhatt sells $115,860 in shares
Septerna, Inc. President and COO Elizabeth Bhatt sold 4,000 shares of common stock for a total of $115,860 on February 18, 2026, following a 370% stock surge over the past year. Concurrently, Bhatt exercised options to acquire an equal number of shares. The transactions were initiated under a Rule 10b5-1 sales plan and leave Bhatt with 174,209 directly owned shares in the biotech company.
Sysco (SYY) PT Lifted by Guggenheim as Firm Highlights Importance of Local Case Growth
Guggenheim has raised its price target for Sysco (SYY) to $95 from $91, maintaining a Buy rating, despite the stock's significant outperformance against the S&P 500 this year, emphasizing the need to monitor local case growth. Sysco recently exceeded Q2 expectations and increased its full-year profit outlook, driven by strong demand in its US business, international sales growth, and effective cost control measures. The company's performance was bolstered by consistent restaurant traffic and sustained spending from higher-income consumers, even as lower-income households showed more caution.
Howard Robin Sells 423 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
Nektar Therapeutics CEO Howard Robin recently sold 423 shares of NKTR stock on February 18th for $73.00 per share, reducing his stake by 0.56%. Following this transaction, Robin now owns 75,489 shares valued at approximately $5.51 million. The stock is trading near its 12-month high of $74.89, with a market capitalization of $1.50 billion.
Septerna president Bhatt sells $115,860 in shares
Septerna's President and COO, Elizabeth Bhatt, sold 4,000 shares of common stock for $115,860 and exercised options for an additional 4,000 shares. These transactions occurred after a significant 370% surge in the stock over the past year. The company, valued at $1.22 billion, also has positive analyst ratings and recent news regarding clinical trials and leadership appointments.
NASDAQ: CVLT Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Commvault Systems, Inc. (NASDAQ: CVLT) Investors to Contact the Firm
Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws by Commvault Systems, Inc. (NASDAQ: CVLT) after the company reported a significant deceleration in SaaS ARR growth for Q3 fiscal 2026, causing its stock to drop over 31%. The law firm is encouraging investors who experienced financial losses to contact them to discuss their legal rights.
RTW INVESTMENTS, LP Acquires Significant Stake in Castle Biosciences Inc.
RTW INVESTMENTS, LP has acquired a substantial stake of 2,115,237 shares in Castle Biosciences Inc. at $38.90 per share, making it 7.20% of their holdings. This strategic investment in the molecular diagnostics company reflects RTW's focus on the healthcare sector and confidence in Castle Biosciences' growth potential. Despite a recent stock price decrease, the company's innovation in medical diagnostics and solid financial strength are highlighted.
Magnetar Financial LLC Acquires 1,485,000 Shares in Crown Reserve Acquisition Corp I
Magnetar Financial LLC has acquired 1,485,000 shares of Crown Reserve Acquisition Corp I (CRAC) for $9.94 per share, marking a new holding in its $9.73 billion portfolio and an 8.60% stake in the blank check company. This strategic investment in the diversified financial services sector highlights Magnetar's focus on growth opportunities despite Crown Reserve Acquisition Corp I's low GF Score of 16/100 and poor profitability and growth ranks. Investors are cautioned to perform thorough due diligence due to the company's current valuation challenges.
Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
ClaimsFiler is reminding investors who lost over $100,000 in Ultragenyx Pharmaceutical Inc. (RARE) to file lead plaintiff applications by April 6, 2026, in a securities class action lawsuit. The lawsuit alleges Ultragenyx failed to disclose material information between August 3, 2023, and December 26, 2025. This action stems from a significant stock price drop after the company announced its Phase 3 Orbit and Cosmic studies for setrusumab in Osteogenesis Imperfecta failed to meet their primary endpoints, leading to plans for substantial expense reductions.
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
ClaimsFiler is alerting investors of uniQure N.V. (NasdaqGS: QURE) who lost over $100,000 to a lead plaintiff deadline of April 13, 2026, in a class-action lawsuit. The lawsuit alleges that uniQure and its executives failed to disclose material information regarding the likelihood of its drug candidate, AMT-130, receiving accelerated FDA approval. The company's stock plummeted after it announced that the FDA no longer agreed that the current data was sufficient for a Biologics License Application (BLA) submission, making the BLA timing unclear.
J. Goldman & Co LP Increases Stake in ProCap Acquisition Corp
J. Goldman & Co LP has increased its holdings in ProCap Acquisition Corp (PCAP) by acquiring an additional 179,057 shares on December 31, 2025. This transaction boosts the firm's total stake to 1,445,321 shares, now representing 0.37% of its portfolio. ProCap Acquisition Corp, a blank check company with a market capitalization of $322.186 million, has a high PE ratio but strong balance sheet, though its profitability and growth ranks are low.
JPMorgan Says Trump’s Debanking Suit Belongs in NY Federal Court
JPMorgan Chase & Co. has requested that Donald Trump's "debanking" lawsuit be moved from Miami to a New York federal court. The bank argues that Trump and his businesses had agreed in writing to litigate any disputes in New York when they opened their accounts. This move aims to ensure the legal proceedings occur in the jurisdiction specified in their initial agreements.
Navient declares first quarter common stock dividend
Navient has announced that its board of directors approved a 2026 first-quarter common stock dividend of $0.16 per share. This dividend is scheduled to be paid on March 20, 2026, to shareholders of record as of the close of business on March 6, 2026. The company helps students and families with higher education costs and focuses on responsible lending and portfolio management.
HK$147.10 intraday: 9988.HK Alibaba HKSE Feb 2026, earnings 24 Feb in focus
Alibaba Group's stock (9988.HK) dropped to HK$147.10 intraday on February 21, 2026, as traders positioned ahead of its earnings report on February 24, 2026. The stock is showing oversold technical indicators, but fundamental metrics like PE 19.85 and EPS 7.41 suggest underlying earnings strength. Meyka AI rates 9988.HK with a "HOLD" grade and forecasts potential upside, while advising caution due to earnings-driven volatility.
